Forma Therapeutics Holdings (FMTX) Misses Q4 EPS by 10c

Forma Therapeutics Holdings (NASDAQ: FMTX) reported Q4 EPS of ($1.06), $0.10 worse than the analyst estimate of ($0.96). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Forma Therapeutics Holdings (FMTX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• KeyBanc Downgrades Kite Realty Group (KRG) to Sector Weight